AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glybonil Plus 5mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

ABS Remedies Pvt Ltd

Salt Composition

Glibenclamide (5mg) + Metformin (500mg)

Overview Glybonil Plus 5mg/500mg Tablet

DiabetaComb 5mg/500mg tablets are classified as antidiabetic agents, combining two medications to manage type 2 diabetes in adults. This medication helps regulate blood glucose in diabetic patients. DiabetaComb 5mg/500mg tablets should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood glucose monitoring. Continue taking this medicine even if you feel well or your blood sugar is controlled; abrupt cessation without medical consultation can lead to elevated blood glucose, risking kidney complications, vision impairment, neuropathy, and limb loss. This medication is one component of a comprehensive treatment plan, including a healthy diet, regular exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. Hypoglycemia (low blood sugar) is a common side effect; learn to identify symptoms like sweating, dizziness, headache, and tremors, and know how to treat them. Maintain regular mealtimes and carry a quick-acting glucose source (e.g., sugary foods or juice). Alcohol consumption increases hypoglycemia risk and should be avoided. Other potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. Do not use if you have type 1 diabetes, diabetic ketoacidosis, or severe kidney or liver disease. Inform your physician of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or breastfeeding individuals should consult their doctor before use. Regular blood glucose monitoring, along with blood cell and liver function tests as advised by your doctor, are necessary.

Uses of Glybonil Plus 5mg/500mg Tablet

Managing type 2 diabetes

Major Benefits of Glybonil Plus 5mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Glybonil Plus 5mg/500mg tablets with a meal.

Common Side effects of Glybonil Plus 5mg/500mg Tablet:

  • Nausea
  • Vomiting
  • Diarrhea
  • Flatulence

How to use Glybonil Plus 5mg/500mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glybonil Plus 5mg/500mg tablets should be administered with food.

How Glybonil Plus 5mg/500mg Tablet works:

Each Glybonil Plus 5mg/500mg tablet contains glibenclamide and metformin, two medications used to manage diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol consumption and Glybonil Plus 5mg/500mg tablets is contraindicated.

PregnancyPregnancySAFE IF PRESCRIBED

The use of Glybonil Plus 5mg/500mg tablets during pregnancy is typically deemed safe. Preclinical trials in animals have revealed minimal or no negative impacts on fetal development; however, data from human trials are scarce.

Breast feedingBreast feedingCAUTION

Use of Glybonil Plus 5mg/500mg tablets requires careful consideration while breastfeeding. Lactation should cease until maternal treatment concludes and the medication is fully cleared from the mother's system.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Glybonil Plus 5mg/500mg Tablet on driving ability is unknown. Refrain from driving if you exhibit any symptoms impairing concentration or reaction time.

KidneyKidneyUNSAFE

Individuals with kidney impairment should likely avoid Glybonil Plus 5mg/500mg tablets due to potential safety concerns. Medical advice is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Glybonil Plus 5mg/500mg tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is unsuitable for individuals with severe hepatic dysfunction.

What if you forget to take Glybonil Plus 5mg/500mg Tablet :

Should you forget to take your Glybonil Plus 5mg/500mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Glybonil Plus 5mg/500mg Tablet

LabelValue
Potential for Dependence None.
Medication Classification Diabetes medication

FAQs on Glybonil Plus 5mg/500mg Tablet

Glybenil Plus 5mg/500mg tablets contain glibenclamide and metformin, working synergistically to manage type 2 diabetes mellitus in adults. This medication enhances blood glucose control when combined with dietary adjustments and physical activity. Glibenclamide stimulates insulin secretion from the pancreas, while metformin reduces hepatic glucose production and improves insulin responsiveness. This dual-agent therapy is unsuitable for type 1 diabetes.
Diabetes mellitus type 2, the prevalent form of diabetes, arises from inadequate insulin production and impaired insulin function. This deficiency results in elevated blood glucose, potentially causing severe health issues. Characteristic symptoms of hyperglycemia encompass frequent urination, excessive thirst, and heightened appetite. Untreated, diabetes significantly increases the risk of long-term complications such as nerve damage (neuropathy), kidney disease (nephropathy), retinopathy (eye damage), foot problems, and cardiovascular disease.
Glybonil Plus 5mg/500mg tablets may cause common side effects including low blood sugar (hypoglycemia), taste changes, nausea, abdominal pain, diarrhea, headache, and upper respiratory infections. Rare but potentially serious side effects such as lactic acidosis can also occur. Prolonged use might result in vitamin B12 deficiency.
Glybonil Plus 5mg/500mg Tablets can induce hypoglycemia (low blood sugar). Symptoms include nausea, headache, irritability, hunger, sweating, dizziness, tachycardia, and anxiety or tremors. Hypoglycemia risk increases with missed or delayed meals, alcohol consumption, excessive physical activity, or concomitant use of other antidiabetic medications. Therefore, consistent blood glucose monitoring is crucial. Always carry a readily available fast-acting carbohydrate source, such as glucose tablets, honey, or fruit juice.
Glybonil Plus 5mg/500mg Tablet's prolonged use can induce vitamin B12 deficiency by hindering its gastric absorption. This deficiency, if left unaddressed, potentially leads to anemia, neurological complications such as peripheral neuropathy (manifesting as tingling, numbness in extremities, and weakness), urinary dysfunction, cognitive impairment, and ataxia. Prophylactic annual supplementation with external vitamin B12 sources is recommended by some studies to mitigate these risks.
Glybonil Plus 5mg/500mg Tablets are contraindicated in individuals with hypersensitivity to any ingredient or inactive component. The medication should not be administered to patients exhibiting moderate to severe renal impairment or those with pre-existing metabolic acidosis, such as diabetic ketoacidosis.
Combining Glybonil Plus 5mg/500mg tablets and alcohol is unsafe. This combination can dangerously reduce blood sugar (causing hypoglycemia) and raise the risk of lactic acidosis.
Retain this medication within its original, sealed container. Follow the storage guidelines provided on the packaging. Discard any leftover medication. Prevent access by children, pets, and others.
Glybonil Plus 5mg/500mg T...
13
MRP 16
18% off